XML 83 R59.htm IDEA: XBRL DOCUMENT
v3.24.3

Financial Assets and Financial Liabilities (Details) |  |  | 12 Months Ended
--- | --- | --- | ---
Feb. 22, 2024 shares | Feb. 28, 2023 £ / shares shares | Jun. 30, 2024 AUD ($) $ / shares shares | Jun. 30, 2024 USD ($) | Jun. 30, 2024 GBP (£) | Jun. 30, 2023 AUD ($) $ / shares | Jun. 30, 2023 GBP (£) | Jun. 30, 2022 AUD ($) $ / shares
Financial Assets and Financial Liabilities [Line Items] |  |  |  |  |  |  |  |
Other income |  |  |  |  |  |  |  |
Total exercise price |  |  |  | $ 965 |  |  |  |
Expire date |  |  | Jul. 31, 2023 | Jul. 31, 2023 | Jul. 31, 2023 |  |  |
Received shares | shares | 471,306 |  |  |  |  |  |  |
Share price | (per share) |  | £ 1.85 | $ 0.27 |  |  | $ 0.27 |  | $ 0.37
Expected number of shares to be received | shares |  | 457,577 |  |  |  |  |  |
R&D grant |  |  | $ 5,375,461 |  |  | $ 2,592,145 |  | $ 657,715
Ateria [Member] |  |  |  |  |  |  |  |
Financial Assets and Financial Liabilities [Line Items] |  |  |  |  |  |  |  |
Revenue | £ |  |  |  |  |  |  | £ 1,000,000 |
Medical Technology Enterprise Consortium [Member] |  |  |  |  |  |  |  |
Financial Assets and Financial Liabilities [Line Items] |  |  |  |  |  |  |  |
Other income |  |  | 28,000 |  |  |  |  |
R&D grant |  |  | $ 1,901,263 |  |  |  |  |
FVPL [Member] |  |  |  |  |  |  |  |
Financial Assets and Financial Liabilities [Line Items] |  |  |  |  |  |  |  |
Share options | shares |  |  | 735,000 |  |  |  |  |
Total exercise price | £ |  |  |  |  | £ 1,470,000 |  |  |
Received shares | shares | 471,306 |  |  |  |  |  |  |

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_OtherRevenue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from the exercise of options. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ProceedsFromExerciseOfOptions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 38 -IssueDate 2024-01-01 -Paragraph 126 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ResearchAndDevelopmentExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of the entity's revenue and other operating income. [Refer: Revenue] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_RevenueAndOperatingIncome
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause vii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Expire date. + References No definition available. + Details
Name: | imrn_ExpireDate
Namespace Prefix: | imrn_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of received shares. + References No definition available. + Details
Name: | imrn_ReceivedShares
Namespace Prefix: | imrn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represent the number of share option under fair value through profit or loss. + References No definition available. + Details
Name: | imrn_ShareOptionUnderFairValueThroughProfitOrLoss
Namespace Prefix: | imrn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of stock bought back by the entity at the exercise price or redemption price. + References No definition available. + Details
Name: | imrn_StockRedeemedOrCalledDuringPeriodShare
Namespace Prefix: | imrn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=imrn_AteriaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=imrn_MedicalTechnologyEnterpriseConsortiumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=imrn_FVPLMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |